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Isabelle Skinner7 and Timothy C. Skinner1,8
Abstract
Background: There is limited Australian epidemiological research that reports on the foot-health characteristics of
people with diabetes, especially within rural and regional settings. The objective of this study was to explore the
associations between demographic, socio-economic and diabetes-related variables with diabetes-related foot
morbidity in people residing in regional and rural Australia.
Methods: Adults with diabetes were recruited from non-metropolitan Australian publicly-funded podiatry services. The
primary variable of interest was the University of Texas diabetic foot risk classification designated to each participant at
baseline. Independent risk factors for diabetes-related foot morbidity were identified using multivariable analysis.
Results: Eight-hundred and ninety-nine participants enrolled, 443 (49.3%) in Tasmania and 456 (50.7%) in Victoria.
Mean age was 67 years (SD 12.7), 9.2% had type 1 diabetes, 506 (56.3%) were male, 498 (55.4%) had diabetes for longer
than 10 years and 550 (61.2%) either did not know the ideal HbA1c target or reported that it was ≥7.0. A majority had
peripheral neuropathy or worse foot morbidity (61.0%). Foot morbidity was associated with male sex (OR 2.42, 95% CI
1.82–3.22), duration of diabetes > 20 years (OR 3.25, 95% CI 2.22–4.75), and Tasmanian residence (OR 3.38, 95% CI 2.35–
4.86).
Conclusions: A high proportion of the regional Australian clinical population with diabetes seen by the publicly-
funded podiatric services in this study were at high risk of future limb threatening foot morbidity, and participants
residing in Northern Tasmania are more likely to have worse diabetes-related foot morbidity than those from regional
Victoria. Service models should be reviewed to ensure that diabetes-related foot services are appropriately developed
and resourced to deliver interdisciplinary evidence-based care.
Keywords: Podiatry, Diabetes, Models of care, Diabetic foot, Australia
Background
People with diabetes mellitus can develop complications
to the lower limb and feet such as peripheral neur-
opathy, [1] peripheral arterial disease, [2] Charcot neuro-
pathic osteoarthropathy, [3] foot ulceration, [4] and
lower limb amputation [5]. Diabetes-related foot compli-
cations rank second behind kidney disease in the burden
of disease for diabetes complications in Australia, [6]
and costs an estimated A$1.6 billion each year [7]. This
equates to an estimated 1.1% of the Australian national
health budget, [8] a proportion similar to that estimated
in the United Kingdom [9]. As a cause of hospital admis-
sion, people with foot complications require inpatient
length of stays longer than any other diabetes complica-
tion [10].
Population-based data from the AusDiab study suggest
the prevalence of peripheral neuropathy in Australia to
be 13% in people with known diabetes, [11] with an in-
creased prevalence of 21% in specialist diabetes clinical
populations [12]. It is estimated that 1.9–5.3% of people
with diabetes in Australia will have experienced a
diabetes-related foot ulcer [13]. Diabetes-related foot
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ulceration resulted in nearly 10,000 Australian hospital
admissions in 2005, with 8% of all diabetes-related
deaths in that year being a direct result of diabetes-
related ulceration [14]. More recently, diabetic foot dis-
ease (ulceration, ischaemia, infection and Charcot neuro-
pathic osteoarthropathy) is estimated to result in 27,600
hospital admissions each year [15]. The number of
diabetes-related lower-limb amputations performed in
Australia has increased from approximately 2600 each
year for the years 1995–1998 [16] to a 2017 estimate of
4400 [15].
Diabetes-related lower limb complications are dispropor-
tionally found in socially disadvantaged and Indigenous
populations. A retrospective Victorian study found a signifi-
cantly higher rate of hospital admissions for people with
diabetes from geographical areas of greater social disadvan-
tage, [17] and Australian Institute of Health and Welfare
statistics suggest a 50% higher probability of lower limb am-
putation for people residing in rural areas [18].
To date, there is limited prospective epidemiological
research that reports on the foot-health characteristics
of people with diabetes, especially within rural and re-
gional settings. The objective of this analysis was to ex-
plore the associations between demographic, socio-
economic and diabetes-related variables with diabetes-
related foot morbidity in people residing in regional and
rural Australia.
Methods
Design
This study was approved by the Human Research Ethics
Committees of the University of Tasmania, Bendigo
Health and La Trobe University. This article reports the
baseline characteristics of those recruited to a longitu-
dinal, prospective cohort study- a prospective cohort study
of diabetes-related foot-health in Australian rural areas
(PoDFAR). The cohort of participants were conveniently
recruited from publicly-funded podiatric services in re-
gional and rural Victoria and Tasmania over two time pe-
riods of three-months during 2013 (March–May and
September–November). For the podiatry services involved
in the study, all patients aged over 18 years with diabetes
who presented during the recruitment periods were con-
secutively invited to participate, with written informed
consent gained prior to enrolment.
Setting
The podiatric services involved in the study are found
within the Greater Bendigo area of the Loddon Mallee
region of central Victoria, and the North and North-
West areas of Tasmania. It is estimated that 7.5% of the
Loddon Mallee population and 8.1% of the Northern
Tasmanian population have a diagnosis of diabetes,
which is higher than the Australian estimate of 4.9%
[19–21]. Data collection was undertaken by multiple po-
diatry services of four publicly funded health organisa-
tions. At the time of the study there were 9.5 full-time-
equivalent podiatrists employed in central Victoria and
8.3 in northern Tasmania, with the health services being
delivered across a regional catchment area of 300,000
people in Victoria [22] and 255,000 people in Tasmania
[23]. Service delivery operations range from large re-
gional hospitals to community health centres, primary
health care settings and outreach programs.
Podiatry services are funded through a mix of state
and federal government sources, and this can influence
eligibility and the profile of patients seen in each service.
In general, demand for services outstrips supply and pri-
ority referral policies are also influential. The services
can be described as community-based (including home
visits), subacute or hospital inpatient care. There is a
similar staff profile working in each of these settings
across the two states. In both states, community services
take up a large proportion of the employed podiatry staff
(82.1% in Victoria and 69.9% in Tasmania). Although
the proportion of staff employed is low in subacute set-
tings in both states (13.7% in Victoria and 18.1% in Tas-
mania), previous Victorian research involving the same
podiatric services suggests that these services deal with
patients with more severe diabetes-related foot morbid-
ity, with more occasions of service per patient than the
other settings [24].
In Victoria, the included podiatric services formally
approach the care of people with diabetes using an
established Podiatry Diabetes Model (PDM) [25]. The
PDM is a health model of care developed with the aim
of assisting efficient and effective management of pa-
tients with diabetes across the entire foot-health risk
spectrum. The model has a set of associated local clin-
ical guidelines adapted from national guidelines [26] to
provide robust evidence-based clinical parameters for
podiatrist clinical decision making. The PDM is under-
pinned by all podiatrists classifying a patient’s foot-
health at each point of contact using the validated Uni-
versity of Texas (UT) diabetic foot risk classification tool
(Table 1) [27, 28]. This classification tool facilitates clin-
ical decision making that considers key risk factors for
ulceration (neuropathy, foot deformity and prior history
of limb threatening diabetes-related foot pathology) and
lower limb amputation (current ulceration, Charcot
neuro-osteoarthropathy, infection and ischaemia). The
use of this tool also facilitates the movement of a patient
to the most appropriate podiatric service by way of the
validated PDM referral pathway [24].
In Tasmania, the podiatric services use the UT diabetic
foot risk classification tool in accordance with the clin-
ical underpinnings of the PDM. The referral pathway of
the PDM was not adopted during the study and the
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clinical guidelines are used as a guide only. The use of
the UT diabetic foot risk classification by the Tasmanian
podiatrists commenced 9months prior to recruitment.
Transition to the new tool was facilitated by two days of
formal training by the developers of the PDM.
Data collection
At the time of the first recruitment period all participating
podiatric services were classifying the foot health of their
patients using the UT risk tool as standard practice at
every point of contact. For the enrolled participants, this
foot-health information and other demographic, diabetes-
related and socio-economic variables were recorded at
baseline. Data collection involved the adoption of point-
of-contact data collection through the use of tablet devices
electronically linked to a central database. Each podiatrist
in each podiatry service had access to a tablet device to
record the variables of interest in a survey application. At
the end of each week all new data collected by podiatrists
were uploaded to a central database for collation.
The primary variable of interest was the UT diabetic
foot risk classification designated to each enrolled par-
ticipant at their baseline visit. The UT risk classification
system was chosen as it has been shown to be a reliable,
valid and predictive tool for identifying future foot-
health outcomes for people with diabetes [27, 28].
Demographic and diabetes-related variables of interest
were age, sex, state of residence, diabetes type and dur-
ation, participants’ self-reported knowledge of optimal
blood glucose control and current smoking status. Post-
code was used to classify participants’ residence accord-
ing to Australian Bureau of Statistics (ABS) Australian
Statistical Geography Standard (ASGS) [29].
Postcodes were also matched to ABS Socio-Economic
Indexes for Areas, Index of Relative Socio-Economic
Disadvantage (IRSD) deciles to derive an estimation of
level of social disadvantage [30]. IRSD takes into account
the collective characteristics of an area’s resident group,
including, among other variables, employment status,
housing expenditure, disability and one-parent house-
holds. IRSD scores (highest proportion of disadvantage)
are ranked in deciles, with lower deciles indicating
higher levels of social disadvantage.
Statistical analysis
Data collected was centrally collated using the survey ap-
plication. This data was exported into an Excel spread-
sheet, checked for accuracy and cleaned. The data was
then imported into Stata 15 (StataCorp: College Station,
Texas) for analysis. Data distributions were investigated
and summarised using means and standard deviations
(SD) for parametric continuous data, medians and inter-
quartile ranges (IQR) for non-parametric data and fre-
quencies with percentages for categorical data. The
number of UT risk categories was consolidated into
three groups: “no neuropathy” (UT category 0), “neur-
opathy, no prior history of pathology” or “neuropathy
with deformity” (UT categories 1 and 2) and “history of,
or current pathology” (UT categories 3–6). The consoli-
dation of risk categories was undertaken to allow for
more robust statistical comparison of patient risk pro-
files in line with evidence-based risk for future ulceration
or lower limb amputation- the primary outcome mea-
sures for the follow-up component of the cohort study.
Bivariate analyses were undertaken to investigate
demographic, diabetes-related and socio-economic vari-
ables within the Victorian and Tasmanian samples, and
variables associated with consolidated UT risk category.
Categorical variables were investigated using Chi-square
tests. Non-parametric age data was square transformed
prior to running a one-way analysis of variance
(ANOVA) for risk group comparisons and the independ-
ent t-test was used for state-based comparisons. The
Kruskal-Wallis test was used to investigate differences in
median IRSD deciles between the three consolidated risk
groups. Variables that were significant on bivariate ana-
lyses were entered into an ordered logistic regression
and the parallel regression assumption was investigated
using the Brant test. This indicated age (squared) and
state of residence violated the parallel assumption. A
generalised ordered logit model was subsequently pro-
duced and adjusted odds ratios with 95% confidence in-
tervals were generated. All tests were two-sided and
differences were accepted at p < 0.05 significance level.
A study sample size power calculation was conducted
during the design phase of the cohort study. This paper
presents descriptive analyses of baseline characteristics, as
part of the larger cohort study. Using a conservative rule-
of-thumb of 50 events per variable, with 7 independent var-
iables plus n = 100 to calculate the minimum sample size
for logistic regression (n = 450), adjusting this for an ordinal
logistic regression the minimal sample size for our model is
675. As 899 participants were included in the model, we
are confident that the model had sufficient power.
Results
The study recruited 899 patients with diabetes mellitus
(Table 2). There were 506 (56.3%) male participants and
Table 1 The University of Texas Risk Classification [27, 28]
0 No neuropathy 1 Peripheral neuropathy 2 Neuropathy with deformity 3 History of pathology
4A Foot ulceration 4B Acute Charcot arthropathy 5 Infected foot 6 Ischaemia
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mean age was 67 years (SD 12.7). Fifty-five percent of
participants had been diagnosed with diabetes for longer
than 10 years and 423 (47.1%) did not know an optimal
HbA1c target. Ranked levels of disadvantage show a me-
dian IRSD decile rank of 3 (range 1–9) with 58.7% of
participants residing in the third most deprived post-
codes (IRSD deciles 1–3). The proportion of participants
recruited was equivalent in each state. There was a
spread of participants across all the individual UT Texas
risk categories, with the majority of the sample having
neuropathy or a worse pathology (n = 548, 61.0%).
After risk category consolidation, there were 351
(39.0%) participants with no neuropathy at baseline, 234
participants (26.0%) with neuropathy and no prior his-
tory of pathology and 314 (34.9%) with history of or
current pathology (Table 3). Bivariate analyses found
women comprised 57.3% of the group with no neur-
opathy, while 70.7% of those with a history of pathology
or current pathology were men (χ2 (2) = 52.8, p <
0.0001). There was no significant difference in the pro-
portion of smokers in each risk group (χ2 (2) = 4.5, p =
0.10). There was also no difference in median IRSD de-
cile between the groups (H = 2.2, p = 0.33). All other var-
iables were associated with UT risk group.
The Victorian sample were over-represented in the
neuropathy/neuropathy with deformity group (n = 160,
68.4%) while the Tasmanian sample comprised a larger
proportion of those with a history of or current pathology
(n = 210, 47.4%) (χ2 (2) = 70.3, p < 0.0001) (Table 4). Tas-
manian participants were younger (t(881) = − 6.9, p <
0.0001), more likely to be diagnosed with Type 1 diabetes
(χ2 (1) = 21.5 p < 0.0001), living with diabetes for longer
than 20 years (χ2 (1) = 9.2, p = 0.002) and residing in outer
regional or remote areas (ASGS RA3-RA5) (χ2 (2) = 250.9,
p < 0.0001). Victorian participants had poorer knowledge
of ideal HbA1c level (χ2 (1) = 9.46, p = 0.002). This differ-
ence remained after excluding those with Type 1 diabetes,
with 61.3% of Victorian participants with type 2 diabetes
reporting an incorrect or unknown ideal target HbA1c
level, compared to 52.9% of Tasmanian participants with
type 2 diabetes (χ2 (1) = 5.88, p = 0.02).
Multivariable analysis of risk factors associated with
consolidated UT risk group
Gender, age, diabetes type, duration of diagnosis (≤ 20
years vs. > 20 years), knowledge of optimal HbA1c level
(< 7.5 vs. don’t know or ≥ 7.5), rurality and state of resi-
dence were entered into a generalised ordered logit
model with consolidated UT risk group (no neuropathy,
neuropathy and deformity or history of/current path-
ology) as the dependent variable. The overall model was
significant [likelihood ratio χ2 (14) = 220.7, p < 0.0001,
pseudo R2 = 0.12]. Diabetes type and knowledge of ideal
HbA1c level were not significantly associated with UT
Table 2 Participant characteristics of n = 899
Variable Mean (SD) or n (%)
or Median (IQR)
Age (years) 67.0 (12.7)
Sex (%)
Male 506 (56.3)
Female 393 (43.7)
Diabetes type (%)
Type 1 83 (9.2)
Type 2 816 (90.8)
Diabetes duration (years)
Newly diagnosed 38 (4.2)
1–5 183 (20.4)
6–10 165 (18.4)
11–15 177 (19.7)
16–20 99 (11.0)
> 20 years 222 (24.7)
Unknown 15 (1.7)
Current smoker
Yes 114 (12.7)
No 785 (87.3)
Self-reported ideal HbA1c target (mmol/L)
< 7.0 349 (38.8)
7.0–7.5 59 (6.6)
7.6–8.0 28 (3.1)
> 8.0 40 (4.4)
Don’t know 423 (47.1)
IRSD decile (median (IQR)) 3 (2–4)
Rurality of residence (ASGC)
Metropolitan (RA1) 0 (−)
Inner regional (RA2) 571 (63.5)
Outer regional (RA3) 293 (32.6)
Remote (RA4) 26 (2.9)
Very remote (RA5) 9 (1.0)
State of residence
Tasmania 443 (49.3)
Victoria 456 (50.7)
UT Risk Classification
No neuropathy 351 (39.0)
Neuropathy 149 (16.6)
Neuropathy and deformity 85 (9.5)
History of pathology 122 (13.6)
Neuropathic ulcer 104 (11.6)
Acute Charcot 8 (0.9)
Infection 25 (2.8)
Ischaemia 55 (6.1)
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risk group. The adjusted odds ratio (OR) for men being
in the history of, or current, pathology group was 2.42
(95% CI 1.82–3.22), for those diagnosed with diabetes >
20 years OR 3.25 (95% CI 2.22–4.75), remote or very re-
mote residence versus inner and outer regional residence
OR 0.65 (95% CI 0.48–0.87) and Tasmanian residence
(OR 3.38, 95% CI 2.35–4.86).
Discussion
This is a large cross-sectional analysis of a regional Aus-
tralian podiatric clinical population. The clinical services
involved in the study are led by podiatrists, with some in-
put from other health professionals such as doctors,
nurses and other allied health professionals. As expected
for this clinical population the podiatric services are deal-
ing with a high proportion (35.1%) of people who have a
current or prior limb threatening pathology, which is
much higher than the population-based AusDiab study
[11]. In all clinics involved a priority system was in place
to facilitate access to the services according to most need,
and in Victoria the referral pathways between the two or-
ganisations are clearly defined by the PDM. Understand-
ing the risk profile of a service is important, because the
predominate independent risk factor for future diabetes-
related limb threatening pathology is a prior history of
limb threatening pathology, with the validation of the UT
Texas risk classification demonstrating a 36-fold increase
in risk for ulceration for people with a history of ulcer-
ation [28]. It is these patients that require a multi-
disciplinary approach to their foot care the most.
Unfortunately, the high prevalence of foot morbidity
in this regional and rural clinical population is consistent
with previous research from regional Victoria, which has
some of the highest rates of hospital admissions related
to diabetes-related foot pathology in the state of Victoria
[17]. Other research conducted in 2010 of a sample of
over one hundred people with diabetes in the region
who attended a subacute service involved in the study
showed an annual incidence of diabetes-related foot ul-
ceration of over 30 %, another very high fig [31]. In gen-
eral, our sample had high levels of social disadvantage.
This is consistent with previous research in this area
which has shown a higher incidence of diabetic foot-
related hospital admissions in less advantaged areas of
Victoria [17]. A recent review of global incidence rates
of diabetes-related lower limb amputations has also
found that social deprivation may be significant in the
development of diabetes-related foot pathology [32].
Table 3 Bivariate relationship analysis of participant characteristics with UT score
Variable No Neuropathy (n = 351) Neuropathy/no prior history of pathology or
neuropathy with deformity (n = 234)
History of or current
pathology (n = 314)
p
Sex
Male 150 (29.6) 134 (26.5) 222 (43.9)
< 0.0001a
Female 201 (51.1) 100 (25.4) 92 (23.4)
Age 65 (13.5) 72 (10.7) 66 (12.0) < 0.0001a
Diabetes type
Type 1 26 (31.3) 12 (14.5) 45 (54.2)
< 0.0001a
Type 2 325 (39.8) 222 (27.2) 269 (33.0)
Diagnosed > 20 years+ 45 (20.3) 52 (23.4) 125 (56.3) < 0.0001a
Current smoker 50 (44.6) 20 (17.9) 42 (37.5) 0.10
Knowledge of ideal HbA1c target (mmol/L)
≤ 7.5 169 (41.4) 89 (21.8) 150 (36.8)
0.03a
> 7.5 or don’t know 182 (37.1) 145 (29.5) 164 (33.4)
IRSD decile (median (IQR)) 3 (2–4) 3 (2–4) 3 (2–5) 0.33
Rurality of residence
Inner regional 223 (39.1) 166 (29.1) 182 (31.9)
0.01aOuter regional 111 (37.9) 58 (19.8) 124 (42.3)
Remote or very remote 17 (48.6) 10 (28.6) 8 (22.9)
State of Residence
Tasmania 159 (35.9) 74 (16.7) 210 (47.4)
< 0.0001a
Victoria 192 (42.1) 160 (35.1) 104 (22.8)
Notes: Data presented as n (%) or mean (SD) or IRSD decile (median (IQR)). Percentages are reported by row. +15 participants who could not provide duration of
diabetes information excluded from this calculation. aStatistically significant
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The 12.7% of participants who reported being a
current smoker in this sample was slightly lower than
the population-based National Drug Strategy Household
Survey [33]. Smoking rates in diabetes tend to parallel
that of the general population, however smokers with
diabetes are at a much higher risk of morbidity and pre-
mature death associated with macrovascular complica-
tions [34]. What was particularly disappointing was
knowledge of diabetes as measured by the participants
reporting what the ideal Hb1Ac level should be, with
nearly half the participants not knowing at all what an
ideal level of diabetes control should be. Asking people
with diabetes about what they think their ideal Hb1Ac
should be is a simple, easy question to ask in clinical
practice to identify individuals who might benefit from
attending a structured self-management education pro-
grams, such as the Dose Adjustment for Normal Eating
or the DESMOND programs [35, 36]. The results from
this study indicate that referral pathways for regional
and rural populations should specifically include access
to diabetes education programs.
Interestingly, in bivariate analysis, participants with
current or prior diabetes-related foot pathology were
shown to be significantly younger than those in the
neuropathy/neuropathy with deformity group. A plaus-
ible explanation is that those with current or prior
Table 4 State-based participant foot-health characteristics
Variable Tasmania (n = 443) Victoria (n = 456) p
Sex
Male 262 (59.1) 244 (53.5)
0.09
Female 181 (40.9) 212 (46.5)
Age 64 (12.9) 70 (11.7) < 0.0001a
Diabetes type
Type 1 61 (13.8) 22 (4.8)
< 0.0001a
Type 2 382 (86.2) 434 (95.2)
Diagnosed > 20 years+ 129 (29.6) 93 (20.8) 0.002a
Current smoker 51 (11.5) 61 (13.4) 0.40
Knowledge of ideal HbA1c target (mmol/L)
≤ 7.5 224 (50.6) 184 (40.4)
0.002a
> 7.5 or don’t know 219 (49.4) 272 (55.4)
IRSD decile (median (IQR)) 3 (2–5) 3 (2–4) 0.33
Rurality of residence
Inner regional 168 (37.9) 403 (88.4)
Outer regional 240 (54.2) 53 (11.6) < 0.0001a
Remote or very remote 35 (7.9) 0 (−)
UT Risk Classification
No neuropathy 159 (35.9) 192 (42.1)
N/A
Neuropathy 63 (14.2) 86 (18.9)
Neuropathy with deformity 11 (2.5) 74 (16.2)
History of pathology 79 (17.8) 43 (9.4)
Neuropathic ulcer 67 (15.1) 37 (8.1)
Acute Charcot 6 (1.4) 2 (0.4)
Infection 19 (4.3) 6 (1.3)
Ischaemia 39 (8.8) 16 (3.5)
Consolidated UT Risk Classification
No neuropathy 159 (35.9) 192 (42.1)
Neuropathy/neuropathy with deformity 74 (16.7) 160 (35.1) < 0.0001a
History of, or current, pathology 210 (47.4) 104 (22.8)
Notes: Data presented as n (%) or mean (SD) or IRSD decile (median (IQR)). Percentages are reported by column. +15 participants who could not provide duration
of diabetes information excluded from this calculation. N/A: not reported due to small expected cell frequencies. aStatistically significant
Perrin et al. Journal of Foot and Ankle Research           (2019) 12:56 Page 6 of 9
diabetes-related foot pathology had a significantly longer
duration of diabetes than the other groups, indicating
that a longer duration diabetes was more influential in
their pathology development than the fact that they were
younger. This is why after multivariable analysis, age
failed to remain an independent predictor of poor foot
health.
Independent risk associations with worse foot morbidity
Males were at more than double the risk of females of be-
ing in the current or prior history of pathology group.
This is consistent with the literature. Population-based co-
hort and case-control studies from Australia and around
the world have found that males have higher levels of per-
ipheral neuropathy, [37, 38] foot ulceration, [31, 39] infec-
tion [40] and lower limb amputation [41, 42]. Men tend to
seek access to health services less than females, perceive
that they have less time for their own health and will en-
gage in fewer health-promoting activities [43]. Duration of
diabetes is an important predictor of foot health in this
study, with diabetes duration of over 20 years increasing
the risk of having a current or prior pathology three-fold.
This is consistent with the AusDiab study, [11] which
showed longer duration of diabetes to be associated with
higher risk, and the known natural history of diabetes-
related foot pathology [38].
This sample had generally high levels of risk for
diabetes-related foot pathology, consistent with other re-
gional and rural Australian data [18]. Although bivariate
analysis found that level of remoteness was associated
with poorer foot health, after the multivariable analysis
(controlling for sex and duration of disease), remoteness
was associated with better foot health. This suggests that
poorer foot-health is less associated with rurality, and
more a function of the characteristics of the patients that
are attending the podiatric clinics in the regional and
rural geographical areas. This is consistent with the large
Australian Diabetes-MILES study, where remoteness
was not associated with worse reported health problems
or self-care indicators [44].
Those residing in the state of Tasmania were at more
than three times the risk of having a current or prior
history of serious diabetes-related foot pathology. This
may be explained by the Tasmanian podiatric services
model, where a higher proportion of podiatrists are
employed in a subacute or acute setting attending to pa-
tients at higher risk of foot morbidity, as opposed to the
Victorian services.
Implications
This study has shown that regional publicly funded podi-
atric services in Australia are managing large numbers of
patients at high risk of diabetes-related foot complications.
National guidelines suggest that patients at high risk of
diabetes-related foot pathology should have involvement
with dedicated multi-disciplinary teams [15, 26]. However,
three-quarters of the services involved in this study utilise
community-based funding for the employment of podia-
trists. Multi-disciplinary care is rarely the focus of Austra-
lian community-based podiatric services, which are more
based on single discipline primary care model. These find-
ings suggest that a high proportion of patients with dia-
betes seen by the podiatric services in this study were at
high risk of future limb threatening foot morbidity, funded
by programs that may not allow support for patients ac-
cording to best recommendations [15, 26].
Further expansion of multi-disciplinary clinics, par-
ticularly outside of metropolitan and larger regional cen-
tres, may not be achievable in the medium term. What
could be achieved is improved utilisation of standardised
clinical guidelines, particularly as Australian research has
shown that in community podiatry settings clinical
guidelines are under-utilised [45]. There are established
and robust risk systems and guidelines that have been
developed that can inform evidenced-based practice in
regional and rural podiatry-led services, such as the UT
risk classification tool used in his study, or more recently
published guidelines from the International Working
Group on the Diabetic Foot [46]. The adoption of the
PDM is an example of health organisations in a local
area implementing models of care that use clinical
guidelines and risk stratification tools to guide patient
access to appropriate services and standardised care.
The PDM provides a relatively simple conceptual ex-
ample for the provision of podiatric services across dif-
ferent health system levels for people with diabetes in
regional Australia [25]. The use of the risk classification
system ensures the model has a sound evidence base,
and the use of the available health service resources are
driven by the clinical needs of the patients matched with
the appropriate skill-set of the service providers. The po-
diatric care of people with diabetes in Australia requires
the development of a seamless and collaborative model
of care established within and across different health set-
tings, with a clear definition of what role each health ser-
vice has with respect to the obligations to the patient
group [7, 45].
Limitations
This study included a population with diabetes who
attended predominately outpatient podiatric clinical set-
tings in regional and rural Australia. As such, care
should be taken when generalising to other populations,
such as metropolitan, hospital inpatients or the general
population of people with diabetes in Australia. This is
particularly pertinent when considering people with dia-
betes in the community who have not developed periph-
eral neuropathy or peripheral arterial disease. This
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population is at a low risk of developing a limb threaten-
ing complication, and foot health care and prevention
strategies do not require a dedicated multi-disciplinary
service. The International Working Group on the Dia-
betic Foot provides strong evidence to recommend an-
nual screening for loss of protective sensation and
peripheral arterial disease, with education to be provided
about appropriate foot self-care and identification of
pre-ulceration signs [47].
Another limitation to this study is the lack of objective
measurement of blood glucose control. Unfortunately, it
was not practical to objectively measure blood glucose
control in this study. The podiatry clinics do not consist-
ently measure blood glucose control as this is primarily
the responsibility of the primary health care giver (gen-
eral practitioners). Causal links between poor glucose
control and the development of peripheral neuropathy
have been previously established [1] so it is probable that
glucose control was correlated with levels of foot health
in this study. However, this was unable to be quantified,
so it is possible that glucose control could be a con-
founding variable in the multivariate analysis. This might
particularly be the case for the strong association found
between state of residence and foot health, where Tas-
manian residents were over three times as likely to have
had history of serious pathology. Further studies of this
nature should include objective measurement of blood
glucose.
Conclusions
A high proportion of the regional Australian clinical
population with diabetes seen by the publicly-funded po-
diatric services in this study were at high risk of future
limb threatening foot morbidity, with participants resid-
ing in Northern Tasmania more likely to have worse
diabetes-related foot morbidity than those from regional
Victoria. Male sex and those diagnosed with diabetes >
20 years were at greater risk of diabetes-related foot
morbidity. There was also a lack of knowledge demon-
strated by the sample of basic diabetes information, indi-
cating low levels of engagement in diabetes care and or
little provision of effective high quality educational ser-
vices to people with diabetes in these regional and rural
areas.
The predominately community-funded podiatry ser-
vices models underpinning these services are not well
supported to provide the necessary multi-disciplinary
care that the current evidence-base suggests is needed.
This includes appropriate access to specialist medical
and diabetes education in addition to the podiatry-lead
services. Service models should be reviewed to ensure
that diabetes-related foot services are appropriately de-
veloped and resourced to deliver sustainable multidiscip-
linary evidence-based care.
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